Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04723537
Status:
TERMINATED
Last Update Posted:
2024-06-06
First Post:
2021-01-18
Brief Title:
Upamostat a Serine Protease Inhibitor or Placebo for Treatment of COVID-19 Disease
Sponsor:
Organization:
RedHill Biopharma Limited